Generic placeholder image

Infectious Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5265
ISSN (Online): 2212-3989

Case Report

A Case Report of Salmonella enterica Meningitis in an Infant: A Rare Entity not to Forget

In Press, (this is not the final "Version of Record"). Available online 25 April, 2024
Author(s): Maria Palyvou*, Evangelia Angeli, George Syrogiannopoulos, Evangelia Farmaki, Marianna Tzanoudaki, Gabriel Dimitriou, Anastasia Varvarigou and Despoina Gkentzi
Published on: 25 April, 2024

Article ID: e250424229335

DOI: 10.2174/0118715265286206240402050756

Price: $95

Abstract

Introduction: Salmonellae are gram-negative, facultatively anaerobic Enterobacteri-aceae consisting of two species, Salmonella enterica and Salmonella bongori. Invasive diseases, such as meningitis, result in hospitalization, short and long-term complications, and high mortality rates.

Case Presentation: A 4-month-old baby girl was admitted to a district hospital because of diarrhea and fever. WBC count, urinalysis, urine cultures, and stool cultures were normal. She was treated with intravenous cefuroxime for 5 days. She was discharged on oral cefprozil for 5 days. After the end of therapy, she was admitted again to the same hospital with fever, diarrhea, vomits, and irri-tability. Cerebrospinal fluid examination revealed pleocytosis, while S. enterica was isolated. Em-pirical therapy with ceftriaxone, amikacin, and dexamethasone was started. Because of intracranial hypertension signs, she was transferred to the pediatric intensive care unit of our tertiary hospital. Therapy continued with intravenous ceftriaxone. Brain MRI revealed subarachnoid space dilata-tion. Increased head circumference and pulsating bregmatic fontanel led to a new cerebral MRI, in which ventricular dilatation and extraparenchymal subdural collection were noted. Ceftriaxone was changed to cefotaxime and ciprofloxacin was added. She remained clinically well; her brain MRI, a week later, showed marked improvement, and the course of intravenous antibiotics for 5 weeks was completed. Her baseline immunodeficiency screening tests were normal and repeat MRI two months post-treatment cessation did not reveal the previous abnormalities.

Conclusion: Invasive Salmonella diseases, such as meningitis, are very uncommon in industrial countries nowadays, and the optimal management is yet not well established. Late onset of com-plications from Salmonella meningitis warrants more thorough neurodevelopmental follow-ups.

[1]
Tindall BJ, Grimont PAD, Garrity GM, Euzéby JP. Nomenclature and taxonomy of the genus Salmonella. Int J Syst Evol Microbiol 2005; 55(1): 521-4.
[http://dx.doi.org/10.1099/ijs.0.63580-0] [PMID: 15653930]
[2]
Wu HM, Huang WY, Lee ML, Yang AD, Chaou KP, Hsieh LY. Clinical features, acute complications, and outcome of Salmonella meningitis in children under one year of age in Taiwan. BMC Infect Dis 2011; 11(1): 30.
[http://dx.doi.org/10.1186/1471-2334-11-30] [PMID: 21272341]
[3]
Patel K, Goldman JL. Safety concerns surrounding quinolone use in children. J Clin Pharmacol 2016; 56(9): 1060-75.
[http://dx.doi.org/10.1002/jcph.715] [PMID: 26865283]
[4]
Antibiotic resistance and NARMS surveillance. Available from: https://www.cdc.gov/narms/faq.html%0A
[5]
European food safety aythority, antimicrobial resistanse in Europe. Available from: https://multimedia.efsa.europa.eu/dataviz-2019/ind
[6]
Brouwer MC, McIntyre P, Prasad K, van de Beek D. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev 2015; 2015(9): CD004405.
[PMID: 26362566]
[7]
Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004; 39(9): 1267-84.
[http://dx.doi.org/10.1086/425368] [PMID: 15494903]
[8]
Bustamante J. Mendelian susceptibility to mycobacterial disease: Recent discoveries. Hum Genet 2020; 139(6-7): 993-1000.
[http://dx.doi.org/10.1007/s00439-020-02120-y] [PMID: 32025907]
[9]
Alsubaie SS, Alrabiaah AA. Clinical characteristics, acute complications, and neurologic outcomes of salmonella meningitis in Saudi infants. J Pediatr Infect Dis 2019; 15: 31-8.
[10]
Guillaumat C, Dang-Duy TL, Levy C, Cohen R, Leblanc A. Salmonella meningitis in newborns and infants. The importance of fluoroquinolones. Arch Pediatr 2008; 15(S15): S161-6.
[http://dx.doi.org/10.1016/S0929-693X(08)75501-5]
[11]
Elouali A, Ouerradi N, Ayad G, Babakhouya A, Rkain M. Salmonella meningitis in a young infant: A case report. Cureus 2023; 15(8): e44147.
[http://dx.doi.org/10.7759/cureus.44147] [PMID: 37753016]
[12]
Shome A, Da Silva PP, Wenger PN, Kumta JN. Neonatal salmonella meningitis with subdural empyema: A case report. Pediatr Infect Dis J 2023; 42(10): e390-2.
[http://dx.doi.org/10.1097/INF.0000000000003996] [PMID: 37310891]
[13]
Chen KM, Lee HF, Chi CS, Huang FL, Chang CY, Hung HC. Obscure manifestations of Salmonella subdural empyema in children: Case report and literature review. Childs Nerv Syst 2011; 27(4): 591-5.
[http://dx.doi.org/10.1007/s00381-010-1274-z] [PMID: 20821214]
[14]
Self JL, Judd MC, Huang J, Fields PI, Griffin PM, Wong KK. Epidemiology of salmonellosis among infants in the united states: 1968–2015. Pediatrics 2023; 151(6): e2021056140.
[http://dx.doi.org/10.1542/peds.2021-056140] [PMID: 37161700]
[15]
Ficara M, Cenciarelli V, Montanari L, et al. Unusual meningitis caused by non-typhoid Salmonella in an Italian infant: a case report. Acta Biomed 2019; 90(2): 333-8.
[http://dx.doi.org/10.23750/abm.v90i2.6866] [PMID: 31125015]

Rights & Permissions Print Cite
© 2025 Bentham Science Publishers | Privacy Policy